Oral Civamide Safety, Tolerability First in Human Study

NCT00802217 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped PK results demonstrated no systemic absorption

Conditions

Healthy

Interventions

DRUG: Civamide
DRUG: Civamide

Sponsor

Winston Laboratories